1 / 1

Germany - Europe's Largest Pharmaceutical Market

Germany, recognized as one of the world's most advanced healthcare markets, serves as a crucial gateway to the EU single market for global companies. With a compound annual growth rate (CAGR) of 6.4% from 2017 to 2022, Germany's pharmaceutical sector thrives, boasting a production value of $37.53 Bn in 2021.

Insights10
Download Presentation

Germany - Europe's Largest Pharmaceutical Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. GERMANY- EUROPE'S LARGEST PHARMACEUTICAL MARKET Germany is one of the most developed healthcare markets in the world and a strategic gateway to the EU single market for international companies. Revenue Of Leading Pharmaceutical Markets In Europe In 2022(In $Bn) Current Health Expenditure Per Capita (In $) Germany France Italy Spain Poland Belgium Austria Sweden Romania Portugal Czechia Netherlands Greece Finland Hungary 2012 $56.32 $4,766 $44.19 2013 $5,100 $38.21 $30.18 2014 $5,307 12.81% $9.61 $8.50 $6.40 $5.43 $5.09 $4.87 $4.35 $3.92 $3.52 $3.13 $3.11 2015 $4,625 2016 $4,743 of Germany's GDP is currently allocated to health expenditure, as of 2021 6.4% 2017 $5,065 2018 $5,504 compound annual growth rate 2017-2022 in the German pharma market $5,478 2019 2020 $5,930 2021 $6,503 Healthcare Expenditure, By Funding 2021 $37.53 Bn $9.44 Bn $110.20 Bn Statutory health insurance 6.21% Households and private non-profit institutions 7.75% R&D investments bypharma companies in Germany in 2021- more than in any other European country Production value in 2021- one of Europe'stop pharmaceutical production locations German pharma exports in 2021- world's leading exporter of medicinal products Statutory long-term care insurance Public budgets 8.64% Private health insurance Other funding sources 53.82% 12.90% 12.69% WHY IS GERMANY A STRONG ECONOMY? Germany isthe EU's largest and mostpopulous economy and the fourth-largest globally by nominal GDP Revenue Of Leading Pharmaceutical Markets In Europe In 2022(In $Bn) GDP By Economic Sector,2021 United States China Japan Germany India United Kingdom France Russia Canada Italy Brazil Australia Korea Mexico Spain Indonesia Saudi Arabia Netherlands Turkey Switzerland $25.46 Agriculture Manufacturing $17.89 $4.24 $4.24 $3.39 $3.08 $2.78 $2.24 $2.14 $2.01 $1.92 $1.70 $1.67 $1.47 $1.42 $1.32 $1.11 $1.01 $0.91 $0.82 Industry Excl. Manufacturing Services 72.2% 72% 72.6% 7.3% 20.3% 20% 18.3% Germany's GDP increased from 2021 to 2022 7.3% 8.3% 6.8% 0.7% 0.7% 0.8% 2013-15 2016-18 2019-21 International trade: Economic structure: In 2021, manufactured products made up84% of total merchandise exports, mineral fuels3%, food 5%, ores and metals3% and agricultural raw materials1%,with other categories accounting for4% of the total. In the same period, manufactured products made up72% of total merchandise imports, mineral fuels9%, food 8%, ores and metals5% and agricultural raw materials1%,with other goods accounting for5% of the total. Total exportswere worth $1,640 Bn in 2022,while total importswere $1,517 Bn. In 2021,services accounted for73% of overall GDP, manufacturing 18%, other industrial activity 8%, and agriculture 1%. Looking at GDP by expenditure,private consumption accounted for49% of GDP in 2021, government consumption 22%, fixed investment23%, and net exports6%. Key Exports,2021 Key Imports,2021 Manufactured Products Manufactured Products 6.9% Ores& Metals Food 10.8% 7.7% Others Mineral Fuels 5.5% Food 8.7% Others 5.2% 83.7% 71.5% PHARMACEUTICAL COMPANIES IN GERMANY Headquarter in Germany

More Related